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SHORT REPORT
Oxygen-dependent hydroxylation by FIH regulates the TRPV3
ion channel
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Jason L. Scragg3, Johana Chicher4, Keyur A. Dave4, Murray L. Whitelaw1, Chris Peers3, Jeffrey J. Gorman4,
Jonathan M. Gleadle5, Grigori Y. Rychkov2 and Daniel J. Peet1,6,`
ABSTRACT
Factor inhibiting HIF (FIH, also known as HIF1AN) is an oxygen-
dependent asparaginyl hydroxylase that regulates the hypoxia-
inducible factors (HIFs). Several proteins containing ankyrin repeat
domains (ARDs) have been characterised as substrates of FIH,
although there is little evidence for a functional consequence of
hydroxylation on these substrates. This study demonstrates that the
transient receptor potential vanilloid 3 (TRPV3) channel is
hydroxylated by FIH on asparagine 242 within the cytoplasmic
ARD. Hypoxia, FIH inhibitors and mutation of asparagine 242 all
potentiated TRPV3-mediated current, without altering TRPV3
protein levels, indicating that oxygen-dependent hydroxylation
inhibits TRPV3 activity. This novel mechanism of channel
regulation by oxygen-dependent asparaginyl hydroxylation is likely
to extend to other ion channels.
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INTRODUCTION
Oxygen sensing is fundamental to all metazoa, and contributes to
development, normal physiology and disease. In mammals, many
acute responses to hypoxia are mediated by ion channels, whereas
chronic responses to hypoxia commonly result in altered gene
expression, mediated by transcription factors such as hypoxia
inducible factors (HIFs).
Factor inhibiting HIF (FIH, also known as HIF1AN) is a 2-
oxoglutarate-dependent dioxygenase that regulates the activity of
the HIFs through oxygen-dependent hydroxylation (Hewitson
et al., 2002; Lando et al., 2002a; Lando et al., 2002b; Mahon
et al., 2001). Several proteins containing ankyrin repeat domains
(ARDs) are substrates for asparaginyl hydroxylation by FIH,
including IKba, p105, Notch and ASPP2 (also known as
TP53BP2) (Cockman et al., 2006; Cockman et al., 2009;
Coleman et al., 2007; Janke et al., 2013; Zheng et al., 2008),
but the functional consequences of hydroxylation remain unclear.
Despite this, FIH-deficient mice display elevated metabolism,
insulin hypersensitivity, hyperventilation and reduced body
weight (Zhang et al., 2010), but no disruption to classical HIF-
regulated pathways such as those regulating angiogenesis,
consistent with a role for non-HIF targets of FIH.
We performed a bioinformatic search to identify novel substrates
of FIH, and identified members of the transient receptor potential
(TRP) ion channel family. We demonstrate that the TRP vanilloid-3
channel (TRPV3) is hydroxylated by FIH, leading to oxygen-
dependent regulation of TRPV3-mediated current.
RESULTS AND DISCUSSION
A bioinformatic search for novel FIH substrates was performed
using a consensus sequence generated from known FIH substrates
(Wilkins et al., 2012). TRP channels, non-selective cation
channels permeable to Ca2+ that perform a range of sensory
roles (Ramsey et al., 2006; Venkatachalam and Montell, 2007),
were identified as likely substrates with predicted hydroxylation
sites within the cytoplasmic ARDs (Fig. 1A). The best candidate
was TRPV3, a channel that is most highly expressed in the skin,
central nervous system, testis and gastrointestinal tract, with roles
in thermosensation, nociception, skin barrier formation, hair
morphogenesis and wound healing (Nilius et al., 2014).
To investigate the ability of FIH to hydroxylate TRPV3 in vitro,
recombinant mouse and human TRPV3-AR3–6 were analysed for
hydroxylation using the [14C]-2-oxoglutarate capture assay (Linke
et al., 2007). The TRPV3-ARD polypeptides produced activity
with FIH that was similar to that of the well-characterised Notch1-
ARD substrate (Coleman et al., 2007; Zheng et al., 2008),
providing strong evidence that TRPV3 is a substrate of FIH
(Fig. 1B). TRPV4 displayed activity slightly above that of the
Notch1-N1945A/N2012A negative control (Zheng et al., 2008),
consistent with FIH inefficiently hydroxylating histidine residues
in ARD substrates (Yang et al., 2011).
Mutation of the predicted target asparaginyl residue to alanine
in mouse (m)TRPV3 (N242A) reduced activity to background
levels (Fig. 1C), consistent with N242 being the predominant
site of hydroxylation. Affinity pull-down assays (Fig. 1D)
demonstrated that recombinant ARDs from TRPV3, but not
TRPV4, efficiently bound to FIH. Importantly, FIH-mediated
hydroxylation of TRPV3 was oxygen-dependent, with activity
greatly reduced in 0.5% oxygen (Fig. 1E). The retention of some
activity in severe hypoxia is not surprising, given that FIH can
remain active under conditions of severe hypoxia (0.2% oxygen)
(Singleton et al., 2011; Tian et al., 2011).
To confirm hydroxylation in vitro, recombinant TRPV3-ARD
expressed in Escherichia coli was analysed by mass spectrometry
(MS) before and after incubation with recombinant FIH. An ion
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corresponding to the unmodified tryptic peptide containing N242
was detected from untreated TRPV3 [mass to charge ratio (m/z)
1919.096]. Incubation of this peptide with FIH resulted in a
modified TRPV3 peptide ion (m/z 1935.079). MALDI-TOF/TOF-
MS/MS analyses (Fig. 2A–C) indicated that N242 was modified
by the addition of one oxygen atom, as unmodified y5–17 fragment
ions could be assigned to the unmodified peptide, but those from
the modified peptide contained an additional oxygen atom.
Hydroxylation within cells was investigated by transfecting
HEK293T cells with full-length TRPV3 fused to an N-terminal
Myc 6-histidine (6his) tag together with FIH. These cells were
then treated with or without dimethyloxalyl glycine (DMOG), an
inhibitor of FIH (Lando et al., 2002a), similar to the functional
experiments shown in Fig. 4. Myc-6his–TRPV3 was affinity
purified, and high-performance electrospray ionisation mass
spectrometry (ESI-MS) of tryptically digested TRPV3 detected
doubly charged ions corresponding to both hydroxylated and
nonhydroxylated peptides containing N242. Tandem mass
spectrometry of these doubly charged peptide ions revealed
ion series (Fig. 2D,E) similar to the y ion fragment series from
the hydroxylated and nonhydroxylated recombinant proteins
described above (Fig. 2B,C), thus confirming hydroxylation of
full-length TRPV3 at N242 within cells. As expected, DMOG
greatly reduced hydroxylation, with the ratio of hydroxylated to
nonhydroxylated TRPV3 peptides decreasing ,30-fold from 1.2
to 0.04 after treatment (Fig. 2F), consistent with hydroxylation
being FIH-dependent. Hydroxylation of N242 was also detected
in HEK293T cells stably expressing TRPV3 (data not shown).
To investigate the function of TRPV3 hydroxylation by FIH,
HEK293T cells were co-transfected with full-length TRPV3 and
GFP. Whole-cell patch recordings showed robust activation of
TRPV3-mediated current in response to application of the
TRPV3 agonist, 2-aminoethoxydiphenyl borate (2-APB) (Fig. 3A,B)
(Chung et al., 2004; Hu et al., 2004). With each consequent
application of 2-APB, the current amplitude increased, saturating
after four to five applications (Fig. 3A). The current–voltage plot
showed characteristic outward rectification (Fig. 3B) (Peier et al.,
2002; Smith et al., 2002; Xu et al., 2002). Current with the same
properties was recorded in HEK293T cells stably transfected with
Myc-6his–TRPV3 used in the mass spectrometry analysis.
Of considerable interest is whether TRPV3 channels are
regulated by hypoxia, with a role for oxygen-dependent
hydroxylation mediated by FIH. To address this question,
HEK293T cells were transfected with TRPV3 and preincubated
under hypoxic conditions (0.1% oxygen) for 24 h prior to
patch clamping, to inhibit endogenous FIH and thus prevent
hydroxylation of TRPV3. Severe hypoxia was used to ensure
inhibition of FIH (Singleton et al., 2011). Hypoxia substantially
increased the TRPV3 current amplitude above that observed during
normoxia (Fig. 3C); the increase in amplitude was sustained over
Fig. 1. Oxygen-dependent hydroxylation of TRPV3 by
FIH in vitro. (A) Results from a bioinformatic search of the
National Center for Biotechnology Information (NCBI)
database for the LXXXXpD/EQN consensus motif (blue and
orange highlighting) using the blastp algorithm. p represents
a small, uncharged residue and Q represents a hydrophobic
residue. (B,C) CO2 capture assay with purified MBP–FIH and
Trx-6his–TRPV-ARD proteins with positive (mNotch1) and
negative [Notch1-NN/AA (mNotch1-N1945A/N2012A)]
controls and Trx-6his–TRPV-ARD-N242A (N242A). mV3,
mouse TRPV3; hV3, human TRPV3; hV4, human TRPV4;
WT, wild type. (D) Affinity pull-down assay with purified Trx-
6his–TRPV-ARD proteins attached to Ni-NTA resin used to
pull-down endogenous mFIH from mouse embryonic
fibroblast whole-cell extracts. IB, immunoblot. Data are
representative of two independent experiments. (E) CO2
capture assay as in B,C under conditions of normoxia (21%
O2) and hypoxia (0.5% O2). CO2 capture assays were
performed in triplicate, and are displayed as the mean6s.d.
(at least three independent experiments).
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Fig. 2. Demonstration of
hydroxylation of N242 of TRPV3 by
tandem mass spectrometry. (A) The
tryptic peptide corresponding to
residues 227–246 of TRPV3, with
hydroxylated asparagine highlighted
with an asterisk. (B,C) Tandem MALDI-
TOF/TOF-MS/MS spectra were
obtained from the hydroxylated (B) and
non-hydroxylated (C) peptides. Isobaric
correspondence between the y3 and y4
fragment ions in both spectra and
subsequent shifts of 16 atomic mass
units (amu) for all subsequently
identified y fragment ions of the
hydroxylated precursor ion relative to
the non-hydroxylated precursor ion are
indicated by dashed lines. The fragment
ions containing hydroxylated
asparagine are indicated by asterisks.
a.u., arbitrary units. (D,E) Tandem mass
spectrometric spectra, similar to those
shown in B,C were obtained by
nanoHPLC-LTQ-Orbitrap analysis of a
tryptic peptide (m/z5968.0176) from
Myc-6his–TRPV3 isolated after
expression under normoxia in HEK293T
cells. (F) Quantification of hydroxylated
and nonhydroxylated tryptic peptides
(A) in HEK293Tcells co-transfected with
Myc-6his–TRPV3 and FIH, with and
without 1 mM DMOG treatment for 16 h.
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repetitive applications of 2-APB (Fig. 3C). Cells were also treated
with DMOG with similar results; an increase in TRPV3-mediated
current was observed after DMOG treatment (Fig. 3D), consistent
with hydroxylation by endogenous FIH inhibiting channel activity
in normoxia and mediating a response of TRPV3 channels to
hypoxia. This is a change in channel activity, as total TRPV3
protein levels do not change when the cells are incubated under
hypoxic conditions or treated with DMOG (Fig. 3E).
Next, FIH and TRPV3 were co-transfected into HEK293T cells to
achieve similar levels of expression. Treatment with DMOG
increased the TRPV3 current amplitude in the presence of
overexpressed FIH (Fig. 4A), consistent with the DMOG-
dependent decrease in hydroxylation demonstrated by mass
spectrometry (Fig. 2F) increasing TRPV3 activity. Overexpression
of the catalytically inactive mutant FIH-H199A (Lando et al.,
2002a), to outcompete endogenous FIH, resulted in similar TRPV3
activity to that observed following overexpression of FIH in the
presence of DMOG (Fig. 4A). These data demonstrate that FIH-
mediated hydroxylation inhibits TRPV3 activity, with reduced
levels of hydroxylation caused by hypoxia, DMOG treatment or
the presence of inactive FIH all increasing TRPV3 current. Unlike
other ARD substrates of FIH, where hydroxylation-dependent
changes in substrate activity are either subtle or are not detected,
this is a clear demonstration of an ARD substrate being regulated
by FIH-mediated hydroxylation.
To confirm the role of TRPV3 hydroxylation at N242, HEK293T
cells were transfected with the hydroxylation-deficient TRPV3-
N242A mutant (Fig. 1C), and the increase in current amplitude in
response to hypoxia was greatly diminished (Fig. 4B), consistent
with hypoxic regulation being mediated predominantly by oxygen-
dependent FIH-mediated hydroxylation at N242. Although
TRPV3-N242A cannot be hydroxylated by FIH, mutation of this
well conserved asparaginyl residue might also influence the ARD
structure, complicating the interpretation of the normoxic activity of
this mutant.
Finally, the hydroxylation-dependent response to acute hypoxia
was investigated. HEK293 cells stably expressing TRPV3 or
TRPV3-N242A were exposed to hypoxia [pO2520.261.7 mmHg
(6s.e.m.), equivalent to,3% oxygen, the lowest level achieved in
these acute hypoxia experiments] for 5 min (Fig. 4C). TRPV3
current amplitude after application of 2-APB increased by more
than twofold after 4 min of hypoxia [Fig. 4D, 63.1613.7 pA/pF
(normoxia) to 208.3625.8 pA/pF (hypoxia), P,0.001, n511]. In
contrast, the TRPV3-N242A mutant showed only a small increase
in response to hypoxia [Fig. 4E, 148.5618.6 pA/pF (normoxia) to
213.1634.7 pA/pF (hypoxia), P,0.05, n512], confirming a role
for FIH-dependent hydroxylation in the acute response of TRPV3
to hypoxia.
These data identify a non-HIF substrate of FIH that is regulated
in an oxygen-dependent manner by hydroxylation. Although
Fig. 3. Heterologously expressed TRPV3
channels are regulated by hypoxia.
(A) Timecourse of outward TRPV3 current recorded
in response to repeated applications of 2-APB (black
bars). Each point represents the amplitude of
current at 100 mV taken from the I–V plots recorded
in response to voltage ramps between 2120 and
120 mV applied every 2 s. Current was normalised
to cell capacitance. (B) Example I–V plot of TRPV3
current recorded in response to a voltage ramp.
(C) Average amplitude of TRPV3 outward (upper
panel) and inward (lower panel) currents recorded at
+100 and 2100 mV, respectively, in response to five
consecutive applications of 2-APB from cells
incubated for 18 h under conditions of normoxia
(n511) or hypoxia (1% O2) (n58). The data are from
HEK293T cells stably transfected with TRPV3. The
effect of hypoxia was significant (P,0.0001; two-
way ANOVA). (D) Average maximum amplitude of
TRPV3 currents recorded in response to five
consecutive applications of 2-APB from cells
incubated for 18 h under control conditions (n56–
12) or with 1 mM DMOG (n55–9). The effect of
DMOG was significant (P50.0077; two-way
ANOVA). Data in C,D show the mean6s.e.m. (§3
independent transfections). (E) Western blot of Myc–
hTRPV3 expression under conditions of 16 h
normoxia (‘N’), hypoxia (‘H’, 0.1% O2) or 1 mM
DMOG (‘D’). Data are representative of three
independent experiments.
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previous studies have identified numerous ARD proteins as
substrates of FIH (Cockman et al., 2006; Cockman et al., 2009;
Coleman et al., 2007; Singleton et al., 2011; Zheng et al., 2008),
hydroxylation has no clear effect on their activity. This led to
the hypothesis that the ARD substrates act to sequester FIH and
consequently modulate HIF hydroxylation and activity (Coleman
et al., 2007). In contrast, hydroxylation of the TRPV3-ARD
clearly influences the TRPV3 channel directly. These data,
together with a recent report on ASPP2 (Janke et al., 2013),
demonstrate that FIH can directly influence the activity of
specific ARD substrates by hydroxylation.
Importantly, given the well-documented role of ion channels in
mediating physiological responses to hypoxia, these findings
demonstrate that hydroxylation by FIH can mediate both acute
and chronic responses to hypoxia, in common with the HIF prolyl
hydroxylases (PHDs), which regulate TRPA1 channel activity
(Takahashi et al., 2011).
Hydroxylation could alter channel multimerisation, interactions
with other proteins that can modulate channel gating or localisation
in the plasma membrane. The recent determination of the TRPV3-
ARD structure demonstrates that the finger between repeats 3 and
4, including N242, is important for TRPV3 activity (Shi et al.,
2013). Mutations of residues within this finger involved in the
formation of hydrogen bonds altered the channel response to 2-
APB. Given that hydroxylation within ARDs can contribute to the
formation of additional hydrogen bonds (Kelly et al., 2009),
hydroxylation by FIH might alter activity the conformation of this
important loop.
The physiological response to hypoxia might have important
implications for known TRPV3 channel functions. For example,
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Fig. 4. Specific mutations in TRPV3 and FIH abolish hypoxic regulation of TRPV3 current. (A) Average maximum amplitude of TRPV3 currents recorded
in response to five consecutive applications of 2-APB in HEK293T cells co-transfected with TRPV3 and either wild type (WT) FIH or FIH-H199A. Cells were
incubated for 18 h in the presence or absence of 1 mM DMOG. Effects of DMOG and FIH-H199A mutation were significant compared to FIH-WT (P50.0065 and
0.0071, correspondingly; two-way ANOVA). There was no difference between FIH-WT+DMOG and FIH-H199A (P50.7; two-way ANOVA). (B) Average
maximum amplitude of TRPV3 currents in response to four consecutive applications of 2-APB in HEK293T cells transiently expressing TRPV3-WT or TRPV3-
N424A, incubated for 18 h in normoxia or hypoxia (1% O2). The effect of hypoxia was significant for TRPV3-WT (P50.0042; two-way ANOVA) but not for the
TRPV3-N424A mutant (P50.14; two-way ANOVA). Data in A,B show the mean6s.e.m. (§3 independent transfections). (C) Schematic of the bath perfusion
protocol during whole-cell patch clamping undertaken to determine the effect of acute hypoxia on TRPV3 current. (D,E) Example timecourse plots of TRPV3
current, measured at +100 mV, evoked by application of 2-APB (50 mM, black bars) under normoxia and hypoxia (pO2 20.261.7 mmHg) for hTRPV3-WT (left)
and TRPV3-N242A (right).
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peripheral nociception is sensitive to hypoxia in animal models of
diabetes (Fuchs et al., 2010), the skin is known to sense and respond
to hypoxia (Boutin et al., 2008), and the role in thermosensation
might be linked to the disrupted thermoregulation observed in
FIH-deficient mice (Zhang et al., 2010), all of which might be
mediated by FIH-dependent hydroxylation. The bioinformatics
strategy also identified up to ten other TRP channels as potential
substrates of FIH, including TRPA1 and TRPC1. Regulation of
TRP channels by FIH might be a widespread mechanism of
oxygen-dependent regulation.
Finally, these results provide a new avenue for potential
therapeutic manipulation of a subset of TRP channels in human
disease. They also have important implications for the development
of novel inhibitors of 2-oxoglutarate-dependent dioxygenases,
including FIH, for the treatment of ischaemic diseases (Nagel
et al., 2010), which could have unexpected consequences on the
activity of TRP channels.
MATERIALS AND METHODS
Plasmids
pcDNA3.1-FIH and pcDNA3.1-FIH-H199A, MBP-FIH (Lando et al.,
2002a), pET32a-mNotch1-ARD and pET32a-mNotch1-ARD-N1945A/
N2012A (Zheng et al., 2008) were as described previously. Human
TRPV3 was amplified from cDNA (Open Biosystems, clone 8143869) and
subcloned into pAdTrack-CMV for use in transient transfections and pEF-
IRES-puro6 (Linke et al., 2007) for generation of stably expressing cells. A
Myc-6his tag was inserted to generate pEF-Myc-6his-hTRPV3-IRES-
puro6. AR 3–6 of human (h)TRPV3 (amino acids 212–364), mTRPV3
(amino acids 212–364) and hTRPV4 (amino acids 235–393) were amplified
by PCR from cDNA clones (Open Biosystems, clones 8143869, 40047664
and 40125997) and cloned into pET-32a (Novagen). hTRPV3-N242A was
generated by site-directed mutagenesis (Quikchange, Stratagene).
Cell culture
Cells were maintained as described previously (Linke et al., 2007;
Scragg et al., 2008). Stable cell lines were generated using pEF-IRES-
puro6-hTRPV3, pEF-IRES-puro6-hTRPV3-N242A and pEF-Myc-6his-
hTRPV3-IRES-puro6 (Lando et al., 2002b; Scragg et al., 2008).
HEK293T cells were transfected by using Polyfect (Qiagen) and
HEK293 cells with Genejammer (Agilent Technologies).
CO2 capture assays
Thioredoxin (Trx)-6his–hTRPV3-ARD3-6, Trx-6his–mTRPV3-ARD3-
6, Trx-6his–hTRPV4-ARD3-6, Trx-6his–mNotch1-ARD1-6 and MBP–
hFIH proteins were generated as described previously (Linke et al., 2007;
Zheng et al., 2008). Hypoxia (1% oxygen) was achieved using an
Edwards Instrument Hypoxia Workstation. All results were obtained
from at least three independent experiments, each performed in triplicate.
In vitro pull-down assays
Recombinant Trx-6his-tagged TRPV proteins were purified and used for
affinity pull-downs as described previously (Linke et al., 2007; Zheng
et al., 2008). Western blotting was performed using an anti-FIH antibody
(Novus Biologicals, NB100-428) as described previously (Linke et al.,
2007; Zheng et al., 2008).
Mass spectrometry
Myc-6his–hTRPV3 was purified from stably expressing HEK293T
cells or cells co-transfected with Myc-6his–hTRPV3 and FIH, using
immobilised metal ion affinity adsorption. Purified protein was then
separated by SDS-PAGE and subjected to in-gel tryptic digestion as
described previously (Hastie et al., 2012; Peet et al., 2004). In-gel digests
were subjected to capillary high performance liquid chromatography
(HPLC) and either arrayed onto matrix-assisted laser desorption
ionisation-time of flight (MALDI-TOF)/TOF targets for MALDI-TOF/
TOF-MS and -MS/MS (Dave et al., 2011) or sprayed directly into the
ion-source of a High-Performance LTQ-Orbitrap Elite mass spectrometer
essentially as described previously (Joubert et al., 2014). Quantification
of hydroxylated versus nonhydroxylated peptides was calculated from the
area under peaks in MS/MS.
Electrophysiology
Whole-cell patch clamping was performed using a computer-based patch-
clamp amplifier (EPC-9, HEKA Electronics, Germany) and PULSE
software (HEKA Electronics). The bath solution contained 140 mM NaCl,
4 mM CsCl, 2 mM CaCl2, 2 mM MgCl2, 10 mM glucose and 10 mM
HEPES (pH 7.4, 2261 C˚). The intracellular solution contained 120 mM
caesium glutamate, 4 mM CaCl2, 5 mM MgCl2, 1 mM MgATP, 10 mM
EGTA and 10 mM HEPES, pH 7.2. Patch pipettes were pulled from
borosilicate glass with a resistance of 3–5 MV. Series resistance did not
exceed 20 MV and was 60–70% compensated. To monitor changes in the
amplitude of the membrane currents, voltage ramps between 2120 and
+120 mV were applied every 2 s, starting after achieving whole-cell
configuration. Acquired currents were filtered at 2.7 kHz and sampled at
10 kHz. The holding potential was 0 mV throughout. Cell capacitance was
compensated automatically by the EPC9 amplifier.
Acute hypoxia experiments
Cells were continuously perfused (3–5 ml/min, 2261 C˚) with bath
solution (as above) gassed either with air or 100% nitrogen, the latter
resulting in a bath pO2 of 20.261.7 mmHg (6s.e.m.; n510) using a
polarised carbon fibre electrode. Pipettes (3–6 MV) were filled with a
solution containing 125 mM CsCl, 3 mM CaCl2, 1 mM MgATP, 5 mM
MgCl2, 10 mM EGTA and 10 mM HEPES, pH 7.3. Series resistance was
monitored throughout, and experiments were terminated if this varied
by .20%. Signals were acquired using an Axopatch200B controlled
by Clampex9.0 software through a Digidata 1322A interface (Axon
Instruments, Inc., Foster City, CA). Data were filtered at 1 kHz and
digitized at 5 kHz. To monitor ionic currents, voltage ramps were used as
described above. Offline analysis was carried out using Clampfit9, and
data are expressed as the mean6s.e.m.
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